Paperpal Prime Logo

Pharmacology and Therapeutics : Impact Factor & More

eISSN: 1879-016XpISSN: 0163-7258

Aims and Scope of Pharmacology and Therapeutics

Pharmacology & Therapeutics is a medical review journal published by Elsevier. It incorporates Pharmacology & Therapeutics. Part A: Chemotherapy, Toxicology and Metabolic Inhibitors and Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology, both originally published by Oxford University Press. Less

Key Metrics

CiteScore
22.2
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
SJR
Q1Pharmacology
SNIP
2.93
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pharmacology and Therapeutics

Pharmacology and Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher PERGAMON-ELSEVIER SCIENCE LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1979
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Pharmacology and Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pharmacology and Therapeutics

Harnessing multispecific antibodies for next-generation cancer treatments.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Corrigendum to "Targeting BRD4 to reverse organ fibrosis: Epigenetic regulation, cellular plasticity, and therapeutic potential" [Pharmacology & Therapeutics, Volume 285, 2026, 109055
  • 1 Oct 2026
  • Pharmacology & therapeutics
Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Metabolic reprogramming in pulmonary arterial hypertension.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Neurotheranostics in Alzheimer's Disease: Current concepts and experimental strategies.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Harnessing multispecific antibodies for next-generation cancer treatments.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Corrigendum to "Targeting BRD4 to reverse organ fibrosis: Epigenetic regulation, cellular plasticity, and therapeutic potential" [Pharmacology & Therapeutics, Volume 285, 2026, 109055
  • 1 Oct 2026
  • Pharmacology & therapeutics
Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Metabolic reprogramming in pulmonary arterial hypertension.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
  • 1 Oct 2026
  • Pharmacology & therapeutics
Neurotheranostics in Alzheimer's Disease: Current concepts and experimental strategies.
  • 1 Oct 2026
  • Pharmacology & therapeutics

FAQs on Pharmacology and Therapeutics